Metallic Nanoparticles in Cancer Therapy explores the innovative use of metallic nanoparticles in cancer therapy. It investigates the production, functionalisation, and medicinal uses of metallic nanoparticles, including iron oxide, gold, and silver, emphasising their potential for targeted drug administration, imaging, and therapy. It also tackles essential regulatory and safety considerations, connecting research with clinical application.
Features:
• Covers specifics to the theranostic application of metallic nanoparticles for cancer treatment.
• Describes therapeutic strategies of nanoparticles in drug administration routes and targeting mechanisms.
• Gives insight about phytochemical and biogenic surface modified metal nanoparticles.
• Discusses bioavailability, and toxicity assessment of metallic nanoparticles
This book is aimed at researchers in metallic nanoparticle, and physicians and regulatory professionals in nanotechnology for precision oncology.
This book covers the complete profile of metal nanoparticles, beginning with their synthesis, characterization, types, applications, and description of therapeutic strategies in drug administration, and targeting mechanisms for cancer cells.
Chapter
1. Introduction to Nanoparticles in Cancer Therapy.
Chapter
2.
Introduction to Metallic Nanoparticles.
Chapter
3. Methods for synthesis and
characterization of metal-based nanoparticles.
Chapter
4. Green synthesis of
gold and silver nanoparticles for cancer therapy application.
Chapter
5.
Green Nanotechnology in Cancer Therapy: State-of-the-art and Future
Perspectives.
Chapter
6. Implication of Gold and Silver Nanoparticles for
Cancer Therapy.
Chapter
7. Implication of Iron and Titanium-based
Nanoparticles for Cancer Therapy.
Chapter
8. Implications of silica-based
nanoparticles for cancer therapy.
Chapter
9. Implication of Zinc Oxide
Nanoparticles for Cancer Therapy.
Chapter
10. Implication of Bismuth and
sulphide Nanoparticles for Cancer Therapy.
Chapter
11. Phytochemicals and
biogenic metal nanoparticles as theranostic for cancer.
Chapter
12. Surface
Modified Metal Nanoparticles for Theranostic Application in Cancer.
Chapter
13. Comparative Analysis of Different Metallic Nanoparticles Based Drug
Delivery System and Their Efficacy in Different Population.
Chapter
14.
Bioavailability, Bio-distribution, and Toxicity Assessment of Metallic
Nanoparticles.
Chapter
15. Regulatory Aspects, FutureProspects, and
Challenges of Metallic Nanoparticles for Cancer Therapy
Ashish Garg is working as a Professor in Guru Ramdas Khalsa Institute of Science and Technology, Pharmacy, Jabalpur, M.P., since March 2024. He has around 12 years of teaching and research experience. He has published more than 125 publications in National and International journals of repute. He is the author of 30 book chapters and editor of 10 books with international publishers in recent concepts of nanotechnology, novel drug delivery systems, cancer targeting, probiotics, and exosomes. He has granted 3 international patents 10 Indian patents.
Neeraj Mishra is a Professor and Head at the Amity Institute of Pharmacy, Gwalior, since July 2019. With over 21 years of teaching and research experience, he has guided 30 M. Pharm and 2 Ph.D. students. A former Brand Ambassador of Bentham Science (2018-19), he has over 120 national and international publications focusing on novel drug delivery, synbiotics, and nanocarriers for cancer and neurodegenerative disorders. He is recognized with multiple awards, including the Distinguished Professor Award (2019, 2021) and Best Academician Award (2023), he also leads an MPCST-funded project on colon-targeted drug delivery for inflammatory bowel disease.
Vikas Pandey is working as an Associate Professor in Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India since July 2022. He has more than 12 years of teaching and research experience with more than 30 publications in International and National reputed journals in recent concept of novel drug delivery system, polymeric drug delivery, localized drug delivery, targeted and controlled drug delivery of nanocarriers and microparticulate system for treatment of various cancers like, lung cancer, colon cancer, brain cancer and neurodegenerative disorders.
S. Mohana Lakshmi is working as a Director and Principal at Amity Institute of Pharmacy, Amity University, Bengaluru. She pursued her PG Degree and Doctorate at Jadavpur University, Kolkata. Her accolades include the "Career Award for Young Teachers" from AICTE, the Fast Track Young Scientist Award from the Department of Science and Technology, and the Gururatna award from the Government of Karnataka. Dr. Lakshmi has successfully executed research projects funded by AICTE and has published over 60 articles in high-impact journals, holding an h-index of 20 and an i10 index of 40.
Nitin K. Jain obtained his M. Pharm. and Ph. D. in Pharmaceutical Sciences from Dr. H. S. Gour University, Sagar, India and Master of Management Sciences from Devi Ahilya University, Indore, India. He works as a Science Manager (Scientist-F) in the Department of Biotechnology, Ministry of Science & Technology, New Delhi. His current job responsibilities include Biosafety Regulation, Animal and Aquaculture Biotechnology program, and handling Policy Planning & Budget activities.
